Following a better-than-expected commercial liftoff for the overactive bladder medicine Gemtesa (vibegron) in its first market, Japan, the Dec. 23 FDA approval for the medicine opens a new commercial ...

Researchers have developed an ultra-soft and highly stretchable tissue-adhesive hydrogel-based multifunctional implantable sensor for monitoring of overactive bladder. Modern living seems to have ...

PITTSBURGH, Dec. 18, 2025 /PRNewswire/ -- A new retrospective study published in the International Urogynecology Journal (DOI: 10.1007/s00192-025-06209-8) by researchers at Allegheny Health Network's ...

Overactive bladder, or OAB, is a condition that causes a sudden urge to urinate. It affects both men and women. The urge may be difficult to stop, and overactive bladder may lead to the involuntary ...

Bladder leakage, also known as urinary incontinence, is a common but often misunderstood condition that refers to the unintentional leakage of urine. About 25 million people in the United States have ...

Actress/TV personality Holly Robinson Peete has partnered up to help raise awareness on the impact of overactive bladder (OAB) and potential treatment options as part of the Time To Go™ Campaign. The ...

Urovant Sciences, Inc and Thinx, Inc Form a Unique Partnership Designed to Educate People Living with The Symptoms of Overactive Bladder (OAB) For Patients With OAB, Traveling or Enjoying a Night Out ...

Combining pelvic floor exercises with behavioral therapy could be more effective than current medical treatments at helping men with frequent urges to urinate, new research in men has found. The ...

In middle-aged and older adults with overactive bladder, the drug selected for treatment may influence the risk for dementia. Investigators conducted a nested case-control study using data from ...

Do you often feel a sudden, intense urge to urinate that disrupts your daily life? If so, you may be experiencing one of the most common overactive bladder symptoms. Understanding the signs to look ...

Credit: Getty Images. Results are from a meta-analysis of 33 trials involving 35,939 patients with overactive bladder. Overactive bladder treatment using antimuscarinic drugs increases the risks for ...

TOKYO, Jul 23, 2025 - (JCN Newswire) - - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and KYORIN Pharmaceutical Co., Ltd.(Headquarters: Chiyoda-ku ...